Cargando…

Toward a New Era in the Management of Hepatocellular Carcinoma: Novel Perspectives on Therapeutic Options and Biomarkers

Detalles Bibliográficos
Autores principales:	Gabbia, Daniela, De Martin, Sara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218986/ https://www.ncbi.nlm.nih.gov/pubmed/37240362 http://dx.doi.org/10.3390/ijms24109018

Ejemplares similares

Tumor Mutational Burden for Predicting Prognosis and Therapy Outcome of Hepatocellular Carcinoma
por: Gabbia, Daniela, et al.
Publicado: (2023)

Lenvatinib in elderly hepatocellular carcinoma patients, a new therapeutic option in first line
por: Roth, Gael S., et al.
Publicado: (2020)

A new era for hepatocellular carcinoma
por: Memeo, Riccardo, et al.
Publicado: (2023)

New Therapeutic Options for Advanced Hepatocellular Carcinoma
por: Ma, Yu-Shui, et al.
Publicado: (2020)

The Use of Epigenetic Biomarkers as Diagnostic and Therapeutic Options
por: Zhang, Le, et al.
Publicado: (2022)

Tivozanib for hepatocellular carcinoma: not likely a new option
por: Estrade, Florian, et al.
Publicado: (2020)

Hepatocellular Carcinoma—How to Determine Therapeutic Options
por: Mehta, Neil
Publicado: (2020)

Biomarkers for hepatocellular carcinoma: What’s new on the horizon?
por: Ocker, Matthias
Publicado: (2018)

Digital Therapeutics in Migraine Management: A Novel Treatment Option in the COVID-19 Era
por: Chen, Xingchen, et al.
Publicado: (2023)

miRNAs in the Era of Personalized Medicine: From Biomarkers to Therapeutics
por: Mc Cormack, Bárbara A., et al.
Publicado: (2021)

Toward a Novel Therapeutic Option for Polycythemia
por: Vinchi, Francesca
Publicado: (2018)

The Quest for Relevant Hepatocellular Carcinoma Biomarkers
por: Kim, Jin U., et al.
Publicado: (2017)

Combination of biomarkers for the detection of hepatocellular carcinoma
por: Sternby Eilard, Malin, et al.
Publicado: (2020)

RNA Therapeutic Options to Manage Aberrant Signaling Pathways in Hepatocellular Carcinoma: Dream or Reality?
por: Sartorius, Kurt, et al.
Publicado: (2022)

Nandrolone decanoate: new therapeutic option for telomeropathies?
por: Frieri, Camilla
Publicado: (2023)

Chemoembolization combined with radiofrequency ablation is the best option for the local treatment of early hepatocellular carcinoma?
por: Kim, Hyo-Cheol
Publicado: (2023)

Special Issue: “Emerging Therapies and Strategies in Thalassemia: Toward a New Era in Management”
por: Ricchi, Paolo, et al.
Publicado: (2022)

Current and Emerging Treatment Options in Sinus and Nasal Diseases: Surgical Challenges and Therapeutic Perspectives
por: Zhao, Xiao-Ying, et al.
Publicado: (2023)

Genetic Biomarkers For Hepatocellular Carcinoma In The Era Of Precision Medicine
por: Duan, Jingxian, et al.
Publicado: (2019)

Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach
por: Sarma, Phulen, et al.
Publicado: (2020)

Advanced nonmetastatic hepatocellular carcinoma: curative surgery may be an option
por: Leclerc, Julie, et al.
Publicado: (2022)

Early Diagnosis of Alzheimer’s Disease: Moving Toward a Blood-Based Biomarkers Era
por: Tao, Qing-Qing, et al.
Publicado: (2023)

Brown Seaweeds for the Management of Metabolic Syndrome and Associated Diseases
por: Gabbia, Daniela, et al.
Publicado: (2020)

Endometriosis: An Inflammatory Disease That Requires New Therapeutic Options
por: Donnez, Jacques, et al.
Publicado: (2022)

Novel Therapies for Hepatocellular Carcinoma
por: Rimassa, Lorenza
Publicado: (2020)

FXYD6: a novel therapeutic target toward hepatocellular carcinoma
por: Gao, Qian, et al.
Publicado: (2014)

Lenvatinib applicability in the therapeutic strategy of patients with hepatocellular carcinoma
por: Merle, Philippe
Publicado: (2023)

Immunotherapy for hepatocellular carcinoma: A promising therapeutic option for advanced disease
por: Cassese, Gianluca, et al.
Publicado: (2022)

Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic options
por: Panneerselvam, Sugan, et al.
Publicado: (2023)

Toward a Better Understanding of Hepatocellular Carcinoma Immune Infiltrates
por: Buettner, Nico, et al.
Publicado: (2019)

Biomarkers in the Era of Precision Oncology
por: Baxevanis, Constantin N.
Publicado: (2023)

Special Issue “miRNAs in the Era of Personalized Medicine: From Biomarkers to Therapeutics 2.0”
por: Mc Cormack, Bárbara Andrea, et al.
Publicado: (2023)

Mesenchymal Stromal Cells: From Therapeutic Option to Therapeutic Target
por: Stefani, Francesca Romana, et al.
Publicado: (2023)

Targeting De Novo Lipogenesis and Cholesterol Biosynthesis Simultaneously is a Novel Therapeutic Option for Hepatocellular Carcinoma
por: Liu, Qian, et al.
Publicado: (2021)

New era towards advancing in girls’ and women’s health and rights?
por: Belizán, José M., et al.
Publicado: (2017)

Hemorrhagic stroke—Pathomechanisms of injury and therapeutic options
por: Chaudhary, Neeraj, et al.
Publicado: (2019)

Leprosy stigma & the relevance of emergent therapeutic options
por: Sardana, Kabir, et al.
Publicado: (2020)

Therapeutic targeting of alternative splicing to inhibit hepatocellular carcinoma metastasis
por: Lee, Yun-Han
Publicado: (2022)

Toward user-friendly and evidence-based practice guidelines for hepatocellular carcinoma
por: Kim, Do Young
Publicado: (2023)

Therapeutic options for the treatment of venous thromboembolism in case of warfarin intolerance: Effects of novel oral anticoagulants
por: Kodani, Eitaro
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fmamq3fgp6un5n72gcehn5dho7